Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 611-033-0 | CAS number: 536759-91-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- genetic toxicity in vivo, other
- Remarks:
- in vivo comet assay
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 01 February 2017 to 09 March 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 017
- Report date:
- 2017
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 489 (In vivo Mammalian Alkaline Comet Assay)
- GLP compliance:
- yes
- Type of assay:
- mammalian comet assay
Test material
- Reference substance name:
- ethyl 1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridine-3-carboxylate
- EC Number:
- 611-033-0
- Cas Number:
- 536759-91-8
- Molecular formula:
- C22H20N4O6
- IUPAC Name:
- ethyl 1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridine-3-carboxylate
- Test material form:
- solid: particulate/powder
- Details on test material:
- powder; stored at room temperature in the dark
Constituent 1
- Specific details on test material used for the study:
- BMS-589152-01
Lot number: 15600T0001
Appearance: Beige-yellowish
Purity/Assay: 100.1% HPLC
Test animals
- Species:
- rat
- Strain:
- Crj: CD(SD)
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- After arrival the weight of the animals was checked and found to be acceptable. The animals were randomly assigned to groups and given a unique tail mark. Each group was kept with the sexes separated in cages. The animals were maintained in a controlled environment with the thermostat and relative humidity target ranges set at 20 to 24°C and 40 to 70%
respectively. The room was illuminated by artificial light for 12 hours per day.
All animals were allowed free access to pelleted Envigo Teklad 2014C diet and tap water ad libitum.
Food, chew blocks and tap water are routinely analysed for quality at source. All animals were given access to small soft white untreated wood (ASPEN) chew blocks and a red plastic shelter for environmental enrichment, were acclimatised for a minimum of 5 days.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- 1% methylcellulose
- Details on exposure:
- All animals in the vehicle control group, BMS-589152-01 dose groups and positive control group were dosed orally by gavage using a dose volume of 10 mL/kg.
- Duration of treatment / exposure:
- The BMS-589152-01 was administered on two occasions approximately 24 hours apart.
- Frequency of treatment:
- 2 times
Doses / concentrationsopen allclose all
- Dose / conc.:
- 2 000 mg/kg bw/day
- Remarks:
- Preliminary study
- Dose / conc.:
- 500 mg/kg bw/day
- Remarks:
- Final Comet assay
- Dose / conc.:
- 1 000 mg/kg bw/day
- Remarks:
- Final Comet Assay
- Dose / conc.:
- 2 000 mg/kg bw/day
- Remarks:
- Final Comet Assay
- No. of animals per sex per dose:
- 2 males/2females in the preliminary study
6 males per dose in the final comet assay - Control animals:
- yes
- Positive control(s):
- Ethyl methanesulfonate (EMS) batch number BCBM2272V, was used as the positive control compound. A solution was prepared using purified water at a concentration of 20 mg/mL just prior to administration.
Vehicle Control group also included
Examinations
- Tissues and cell types examined:
- Cell suspensions from the liver and duodenum were obtained from animals in the vehicle control group and in each of the BMS-589152-01 groups 3 hours after administration of the second dose. Cell suspensions from animals in the positive control group were obtained approximately 3 hours after a single dose.
- Details of tissue and slide preparation:
- Sections of the liver and duodenum were placed into ice cold mincing solution; all samples were stored on ice before processing for Comet analysis. Single cell suspensions were prepared using a tissue specific method.
Comet slides were prepared from all cell suspensions. Sections of the liver and duodenum were stored in 10% buffered formalin and stored within Cell and Molecular Sciences.
Slide Preparation
Glass slides were dipped in 1% normal melting point agarose and left to air dry prior to addition of the cell suspension layer. For each tissue type, an appropriate dilution of the cell suspensions were made and mixed with the appropriate volume of 0.5% low melting point agarose. A 75µL aliquot of the cell/agar mix was dispensed onto the appropriate pre-dipped slides and cover-slipped.
Once the agar had set the cover slips were removed and the slides immersed in chilled lysis solution in a light proof box. These were stored refrigerated overnight prior to electrophoresis. - Evaluation criteria:
- The following criteria were applied for assessment of assay acceptability: The concurrent vehicle control is considered acceptable for addition to the laboratory
historical vehicle control database. Concurrent positive control should induce responses that are compatible with those generated
in the historical positive control database and produce a statistically significant increase compared with the concurrent negative control.
A maximum tolerated dose or maximum feasible dose has been achieved. Adequate numbers of cells and doses have been analysed - Statistics:
- For Groups 1, 2, 3 and 4, Bartlett’s test for variance homogeneity (Bartlett 1937) was applied.
If this test was not significant at the 1% level, then parametric analysis was applied. The F1 approximate test was applied to Groups 1 to 4. This test is designed to detect significant
departure from monotonicity of means when the main test for the comparison of the means is a parametric monotonic trend test, such as Williams’ test (Williams 1971, 1972). The test
statistic compares the mean square, NMS, for the deviations of the observed means from the maximum likelihood means, calculated under a constraint of monotonicity with the usual
error mean square, MSE. The null hypothesis is that the true means are monotonically ordered. The test statistic is F1 = NMS/MSE which can be compared with standard tables of
the F distribution with 1 and error degrees of freedom. If the F1 test was not significant at the 1% level, Williams' test for a monotonic trend was applied to compare Groups 2, 3 and 4 to
the vehicle control group; otherwise Dunnett's test (Dunnett 1955, 1964) was performed instead. If Bartlett's test was significant at the 1% level, then logarithmic and square-root transformations were tried. If Bartlett's test wasstill significant, then non-parametric tests were applied. The H1 approximate test, the non-parametric equivalent of the F1 test described above, was applied to Groups 1 to 4. This test is designed to be used when the
main test for comparison of the means is a non-parametric monotonic trend test, such as Shirley's test. If the H1 test was not significant at the 1% level, Shirley's test for a
monotonic trend (Shirley 1977) was applied to compare Groups 2, 3 and 4 to the vehicle control group, otherwise Steel's test (Steel 1959) was performed instead.
Groups 1 and 5, Bartlett’s test for variance homogeneity was applied. If this test was not significant at the 1% level, then parametric analysis was applied.
Statistical significance was at the 5% level.
Results and discussion
Test results
- Key result
- Sex:
- male
- Genotoxicity:
- negative
- Remarks:
- NO effects seen at 500, 1000 and 2000mg/kg/day
- Toxicity:
- no effects
- Remarks:
- no effects see up to limit dose of 2000mg/kg
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
Applicant's summary and conclusion
- Conclusions:
- It is concluded that BMS-589152-01 has not shown any evidence of causing an increase in DNA strand breaks or cytotoxicity in the liver or duodenum of male Crl:CD(SD) rats when administered orally by gavage in this in vivo test procedure
- Executive summary:
This study was designed to assess the potential of BMS-589152-01 to induce DNA strand breaks in the liver and duodenum of male Crl:CD (SD) rats. Animals were treated with BMS-589152-01 orally on two occasions, the second dose being administered approximately 24 hours after the first dose and 3 hours before sampling. All animals in the vehicle control, positive control and BMS-589152-01 dose groups were dosed orally by gavage using a dose volume of 10 mL/kg. A preliminary toxicity test has shown that a dose of 2000 mg/kg/day, (the standard limit dose for the comet test) administered on two consecutive occasions approximately 24 hours apart was tolerated. On the basis of this result, dose levels of 500, 1000 and 2000 mg/kg/day were selected for the comet test. No substantial differences in toxicity were observed between the sexes in the preliminary toxicity test, therefore, in line with current guidelines the test was performed using male animals only. The vehicle control group received 1% methylcellulose and the positive control group received Ethyl methanesulfonate at 200 mg/kg. Cell suspensions from the liver and duodenum were obtained from animals in the vehicle control group and in each of the BMS-589152-01 groups 3 hours after administration of the second dose. Cell suspensions from animals in the positive control group were obtained approximately 3 hours after a single dose. Following electrophoresis three slides per animal per tissue were analysed for comets. Slides were visualised by staining with SYBR GOLD® via fluorescence microscopy. 150 morphologically normal cells were analysed for the presence of comets per animal per tissue. DNA strand breaks were assessed by comparing the mean and median % tail intensities (% TI) from BMS-589152-01 treated animals with vehicle control values. The slides were also examined for any overt toxicity, e.g. an increase in background debris and/or an increase in the incidence of excessively damaged cells (i.e. ‘Hedgehog’ or ‘Ghost’ cells). These cells were excluded from the analysis, along with any cells that had unusual staining artefacts. Results No statistically significant increases in the % TI were observed in the liver or duodenum of male Crl:CD(SD) rats administered BMS-589152-01 at any dose level, compared with vehicle control values. The positive control compound, Ethyl methanesulfonate, produced statistically significant increases in the % TI when compared with vehicle control values. No Hedgehog “Ghost” cells were observed in either the liver or duodenum of male Crl:CD(SD) rats administered BMS-589152-01 at any dose level.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.